In this study, our integrative analyses across multiple scRNA-seq transcriptomic datasets further reveal that SPP1+BCL2A1+ TAMs are a distinct and clinically relevant immune subset in HCC. The gene discussed is BCL2A1; the disease is hepatocellular carcinoma.